We are live on ! Find out more
CELGZ

Celgene Corporation Contingent Value Rights

Delisted

CELGZ was delisted on the 29th of November, 2019.

26 hedge funds and large institutions have $33.3M invested in Celgene Corporation Contingent Value Rights in 2013 Q2 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+26
Holders Change %
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
26
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Northwestern Mutual Wealth Management
26
Northwestern Mutual Wealth Management
Wisconsin
+$406 +56 New

CELGZ Hedge Fund Activity: Q2 2013 in Review

26 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q2 2013, worth a combined $33.3M.

Buyers outnumbered sellers: 26 funds opened new CELGZ positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.

  • 26 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $33.3M of Celgene Corporation Contingent Value Rights stock for Q2 2013.
  • 26 funds opened new Celgene Corporation Contingent Value Rights positions in Q2 2013 and 0 closed out, a net change of +26 holders.

Based on aggregated 13F filings for Q2 2013.